teleABLE to Reduce Post-Stroke Sedentary Behavior

Launched by UNIVERSITY OF MINNESOTA · Mar 8, 2024

Keywords

ClinConnect Summary

The clinical trial titled "teleABLE to Reduce Post-Stroke Sedentary Behavior" is studying a program designed to help adults who have had a stroke within the last year become more active and improve their overall health. Researchers want to see if a remote program called "teleABLE," which focuses on encouraging physical activity, is more effective than a standard health education program in reducing the amount of time people spend sitting and improving their quality of life.

To participate in this study, individuals must be at least 18 years old, have experienced a stroke in the past 12 months, and typically sit for over six hours a day. Participants will complete questionnaires and wear a small activity monitor at different points during the study. They will also attend either the teleABLE sessions (12 sessions) or the health education sessions (6 sessions). Importantly, participants need to have access to a device like a smartphone or computer for video calls and should have someone to support them through the process. The study is currently recruiting participants of all genders aged 18 and older who meet these criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: 18 years or older
• • Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment
• • ≥6 hours of sedentary behavior on a typical weekday (Sedentary Behavior Questionnaire)
• • Able to walk 150 feet or more without physical assistance from another person, with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
• • Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application
• • Able to identify a support person with whom they have a face-to-face interaction at least one time per week.
• • Able and willing to participate fully in the study and provide informed consent
• Exclusion Criteria:
• • Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility
• • Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent)
• • Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma)
• • Comorbid cancer, currently undergoing chemotherapy or radiation treatment
• • Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)
• • Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
• • Diagnosis of a terminal illness and/or currently receiving hospice care
• • Currently pregnant or expecting to become pregnant in the next 6 months
• • History of skin sensitivity that precludes the use of medical tape necessary for adherence to activity monitor measure
• • Inability to speak, read, or understand English
• • Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)
• • Investigator discretion for safety or adherence reasons